Ezetimibe and Simvastatin
- Product NDC
- 50090-4772
- 11-digit product format
- 500904772
- Labeler code
- 50090
- Product ID
- 50090-4772_c47669cc-ed22-4780-804f-d5859d01dff9
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ezetimibe and Simvastatin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA209222
- Marketing category
- ANDA
- Marketing start
- 2017-12-24
- Substance
- EZETIMIBE; SIMVASTATIN
- Active strength
- 10; 40 mg/1; mg/1
- Pharmacologic classes
- Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A209222-001 | EZETIMIBE AND SIMVASTATIN | EZETIMIBE; SIMVASTATIN | 10MG;10MG | TABLET / ORAL | AB | 2017-12-22 | |
| A209222-002 | EZETIMIBE AND SIMVASTATIN | EZETIMIBE; SIMVASTATIN | 10MG;20MG | TABLET / ORAL | AB | 2017-12-22 | |
| A209222-003 | EZETIMIBE AND SIMVASTATIN | EZETIMIBE; SIMVASTATIN | 10MG;40MG | TABLET / ORAL | AB | 2017-12-22 | |
| A209222-004 | EZETIMIBE AND SIMVASTATIN | EZETIMIBE; SIMVASTATIN | 10MG;80MG | TABLET / ORAL | AB | 2017-12-22 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A209222-001 | AB |
| A209222-002 | AB |
| A209222-003 | AB |
| A209222-004 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A209222-001 | EZETIMIBE AND SIMVASTATIN | 10MG;10MG | TABLET / ORAL | AB | 2017-12-22 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A209222-002 | EZETIMIBE AND SIMVASTATIN | 10MG;20MG | TABLET / ORAL | AB | 2017-12-22 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A209222-003 | EZETIMIBE AND SIMVASTATIN | 10MG;40MG | TABLET / ORAL | AB | 2017-12-22 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A209222-004 | EZETIMIBE AND SIMVASTATIN | 10MG;80MG | TABLET / ORAL | AB | 2017-12-22 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209222-001 | EZETIMIBE AND SIMVASTATIN | 10MG;10MG | TABLET / ORAL | AB | 2017-12-22 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209222-002 | EZETIMIBE AND SIMVASTATIN | 10MG;20MG | TABLET / ORAL | AB | 2017-12-22 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209222-003 | EZETIMIBE AND SIMVASTATIN | 10MG;40MG | TABLET / ORAL | AB | 2017-12-22 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209222-004 | EZETIMIBE AND SIMVASTATIN | 10MG;80MG | TABLET / ORAL | AB | 2017-12-22 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209222-001 | EZETIMIBE AND SIMVASTATIN | 10MG;10MG | TABLET / ORAL | AB | 2017-12-22 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209222-002 | EZETIMIBE AND SIMVASTATIN | 10MG;20MG | TABLET / ORAL | AB | 2017-12-22 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209222-003 | EZETIMIBE AND SIMVASTATIN | 10MG;40MG | TABLET / ORAL | AB | 2017-12-22 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209222-004 | EZETIMIBE AND SIMVASTATIN | 10MG;80MG | TABLET / ORAL | AB | 2017-12-22 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A209222-001 | EZETIMIBE AND SIMVASTATIN | 10MG;10MG | TABLET / ORAL | AB | 2017-12-22 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A209222-002 | EZETIMIBE AND SIMVASTATIN | 10MG;20MG | TABLET / ORAL | AB | 2017-12-22 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A209222-003 | EZETIMIBE AND SIMVASTATIN | 10MG;40MG | TABLET / ORAL | AB | 2017-12-22 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A209222-004 | EZETIMIBE AND SIMVASTATIN | 10MG;80MG | TABLET / ORAL | AB | 2017-12-22 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209222-001 | EZETIMIBE AND SIMVASTATIN | 10MG;10MG | TABLET / ORAL | AB | 2017-12-22 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209222-002 | EZETIMIBE AND SIMVASTATIN | 10MG;20MG | TABLET / ORAL | AB | 2017-12-22 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209222-003 | EZETIMIBE AND SIMVASTATIN | 10MG;40MG | TABLET / ORAL | AB | 2017-12-22 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209222-004 | EZETIMIBE AND SIMVASTATIN | 10MG;80MG | TABLET / ORAL | AB | 2017-12-22 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209222-001 | EZETIMIBE AND SIMVASTATIN | 10MG;10MG | TABLET / ORAL | AB | 2017-12-22 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209222-002 | EZETIMIBE AND SIMVASTATIN | 10MG;20MG | TABLET / ORAL | AB | 2017-12-22 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209222-003 | EZETIMIBE AND SIMVASTATIN | 10MG;40MG | TABLET / ORAL | AB | 2017-12-22 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209222-004 | EZETIMIBE AND SIMVASTATIN | 10MG;80MG | TABLET / ORAL | AB | 2017-12-22 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209222-001 | EZETIMIBE AND SIMVASTATIN | 10MG;10MG | TABLET / ORAL | AB | 2017-12-22 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209222-002 | EZETIMIBE AND SIMVASTATIN | 10MG;20MG | TABLET / ORAL | AB | 2017-12-22 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209222-003 | EZETIMIBE AND SIMVASTATIN | 10MG;40MG | TABLET / ORAL | AB | 2017-12-22 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209222-004 | EZETIMIBE AND SIMVASTATIN | 10MG;80MG | TABLET / ORAL | AB | 2017-12-22 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209222-001 | EZETIMIBE AND SIMVASTATIN | 10MG;10MG | TABLET / ORAL | AB | 2017-12-22 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209222-002 | EZETIMIBE AND SIMVASTATIN | 10MG;20MG | TABLET / ORAL | AB | 2017-12-22 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209222-003 | EZETIMIBE AND SIMVASTATIN | 10MG;40MG | TABLET / ORAL | AB | 2017-12-22 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209222-004 | EZETIMIBE AND SIMVASTATIN | 10MG;80MG | TABLET / ORAL | AB | 2017-12-22 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209222-001 | EZETIMIBE AND SIMVASTATIN | 10MG;10MG | TABLET / ORAL | AB | 2017-12-22 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209222-002 | EZETIMIBE AND SIMVASTATIN | 10MG;20MG | TABLET / ORAL | AB | 2017-12-22 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209222-003 | EZETIMIBE AND SIMVASTATIN | 10MG;40MG | TABLET / ORAL | AB | 2017-12-22 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209222-004 | EZETIMIBE AND SIMVASTATIN | 10MG;80MG | TABLET / ORAL | AB | 2017-12-22 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209222-001 | EZETIMIBE AND SIMVASTATIN | 10MG;10MG | TABLET / ORAL | AB | 2017-12-22 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209222-002 | EZETIMIBE AND SIMVASTATIN | 10MG;20MG | TABLET / ORAL | AB | 2017-12-22 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209222-003 | EZETIMIBE AND SIMVASTATIN | 10MG;40MG | TABLET / ORAL | AB | 2017-12-22 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209222-004 | EZETIMIBE AND SIMVASTATIN | 10MG;80MG | TABLET / ORAL | AB | 2017-12-22 | d8e5a09893c0… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A209222-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A209222-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A209222-003 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A209222-004 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A209222-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209222-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209222-003 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209222-004 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209222-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209222-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209222-003 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209222-004 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A209222-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A209222-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A209222-003 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A209222-004 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209222-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209222-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209222-003 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209222-004 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209222-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209222-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209222-003 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209222-004 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209222-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209222-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209222-003 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209222-004 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209222-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209222-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209222-003 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209222-004 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209222-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209222-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209222-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209222-004 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209222-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209222-002 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209222-003 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209222-004 | AB | 1 | d8e5a09893c0… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Ezetimibe and Simvastatin
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| EZETIMIBE | 10 mg/1 |
| SIMVASTATIN | 40 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| EOR26LQQ24 | Internal UNII lookup |
| AGG2FN16EV | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 476350 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 2ce219a2-1eeb-4ece-bb87-3810e593ca51 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 5347abc9-d72b-9efb-f582-cc87efafcf1b | Product name | 4 | 20250729 |
| 6c13b22c-b3ba-4127-b768-0132dd5ab0d1 | Product name | 1 | 20230829 |
| 91774e91-b249-45e3-8ff8-4b5db2927a69 | Product name | 1 | 20230718 |
| 93a156a6-903b-1690-4dc3-a57adfaa8c1a | Product name | 9 | 20230322 |
| c8f25656-847a-4de8-96a7-06bf98d83c2b | Product name | 1 | 20210916 |
| b249faa8-b784-47ef-8ad4-031ef248fa73 | Product name | 1 | 20200626 |
| c4422d73-8e69-1539-606a-32a25fa00ebc | Product name | 4 | 20190926 |
| 43d7afbf-e4f7-4bf9-9d8f-6c620b3b3db6 | Product name | 1 | 20160615 |
| 0a5e5249-329b-0cff-e714-77159f193a87 | Product name | 1 | 20140508 |
| 46fdf265-6d5a-1bfb-93db-d82a4ea8aa81 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-4772-0 | Ezetimibe and Simvastatin | 90 in 1 BOTTLE | TABLET | 90 | 7 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-4772-0 | EA - Each | 50090-4772 | 33fd0721-7f35-4f61-bc3a-2c1b2cad54ac | 1 | 2026-03-17 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-4772 | EZETIMIBE AND SIMVASTATIN TABLET [A-S MEDICATION SOLUTIONS] | 5 | Current NDC, Legacy NDC, 1 package rows | 20230208_2ce219a2-1eeb-4ece-bb87-3810e593ca51.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ezetimibe and Simvastatin | EZETIMIBE AND SIMVASTATIN | A-S Medication Solutions | 2ce219a2-1eeb-4ece-bb87-3810e593ca51 | 2026-02-06 | Warnings, Adverse reactions | 209222 ANDA209222 50090-4772 |
| Ezetimibe and Simvastatin | EZETIMIBE AND SIMVASTATIN | Ascend Laboratories, LLC | c90e8c96-e130-42d7-bf0d-5833652e40d5 | 2025-05-02 | Warnings, Adverse reactions | 209222 ANDA209222 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 476350 | ezetimibe 10 MG / simvastatin 40 MG Oral Tablet | PSN | 2ce219a2-1eeb-4ece-bb87-3810e593ca51 | 7 |
| 476350 | ezetimibe 10 MG / simvastatin 40 MG Oral Tablet | SCD | 2ce219a2-1eeb-4ece-bb87-3810e593ca51 | 7 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 50090-4772-0 | 50090477200 | 90 TABLET in 1 BOTTLE (50090-4772-0) | 90 tablet | 2019-12-02 | 0000-00-00 | No | No | Current |